AI assistant
Sending…
Baker Hughes Co — Director's Dealing 2017
Jul 3, 2017
30019_dirs_2017-07-03_21a0ac1e-a8fb-46a7-8844-8baacbc1333b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Baker Hughes a GE Co (BHGE)
CIK: 0001701605
Period of Report: 2017-07-03
Reporting Person: CAZALOT CLARENCE P JR (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Class A Common Stock | 39198 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $64.78 | 2017-07-24 | Class A Common Stock (303.0) | Direct | |
| Stock Option (Right to Buy) | $52.42 | 2018-01-23 | Class A Common Stock (357.0) | Direct | |
| Stock Option (Right to Buy) | $59.7 | 2018-08-11 | Class A Common Stock (323.0) | Direct | |
| Stock Option (Right to Buy) | $11.68 | 2019-01-21 | Class A Common Stock (1028.0) | Direct | |
| Stock Option (Right to Buy) | $22.02 | 2019-07-22 | Class A Common Stock (759.0) | Direct | |
| Stock Option (Right to Buy) | $29.78 | 2020-01-19 | Class A Common Stock (634.0) | Direct | |
| Stock Option (Right to Buy) | $31.67 | 2020-07-21 | Class A Common Stock (1155.0) | Direct | |
| Stock Option (Right to Buy) | $44.82 | 2021-01-26 | Class A Common Stock (1077.0) | Direct | |
| Stock Option (Right to Buy) | $59.5 | 2021-07-19 | Class A Common Stock (871.0) | Direct | |
| Stock Option (Right to Buy) | $29.94 | 2022-01-25 | Class A Common Stock (1700.0) | Direct | |
| Stock Option (Right to Buy) | $21.8 | 2022-07-16 | Class A Common Stock (2053.0) | Direct |
More from Baker Hughes Co
Regulatory Filings
2026
May 21
M&A Activity
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 19
Share Issue/Capital Change
2026
May 19
Share Issue/Capital Change
2026
May 19
Annual Report
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Proxy Solicitation & Information Statement
2026
Mar 30
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Mar 2